Drug Type CAR-T |
Synonyms CYAD03 |
Target |
Mechanism IL-18 replacements(Interleukin 18 replacements), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | BE | 06 Apr 2023 | |
Solid tumor | Preclinical | BE | 06 Apr 2023 |